Upregulated interleukin‐6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma
Despite the role of epidermal growth factor receptor (EGFR) signaling in head and neck squamous cell carcinoma (HNSCC) development and progression, clinical trials involving EGFR tyrosine kinase inhibitors (TKIs) have yielded poor results in HNSCC patients. Mechanisms of acquired resistance to the E...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2015-08-01
|
| Seri Bilgileri: | Molecular Oncology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1016/j.molonc.2015.03.008 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|